Home : FDA Drug Database : Actiq : Newsfeeds

Actiq - Newsfeeds

Archived Pharmaceutical News Stories - June 2010: News-Medical.Net provides this medical information service in accordance with these terms and conditions . Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician ...
Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference: RICHMOND, Calif., Jan. 5, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an ...
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011: Abstral is a fast-acting and rapidly disintegrating sublingual tablet formulation of fentanyl citrate designed for oral transmucosal delivery. The product offers an alternative therapeutic choice to patients and clinicians with a simple, patient friendly ...
Watson Pharma Gets FDA Nod For Generic Version Of Cephalon's Fentora Tabs: s (CEPH: News ) Fentora tablets. The FDA approved Watson's Fentanyl Citrate Buccal tablets in the 100 mcg, 200 mcg, 300 mcg, 400 mcg and 800 mcg strengths. Fentanyl Citrate Buccal tablets are indicated to treat breakthrough pain in adult patients with ...
Ex-Paramedic Sentenced For Stealing Narcotic: In May, paramedics conducting a supply check found a vial of the painkiller Fentanyl had been tampered with. Fentanyl citrate is a liquid drug that is 10 times stronger than morphine and used as a painkiller for heart attack victims. The U.S. Attorney's ...
Former Wash. fire captain sentenced for stealing, using painkiller: CAMAS, Wash. — Bradley Curtis Allen, a fired Camas Fire Department captain and paramedic, has been sentenced to more than two years in prison for stealing the narcotic painkiller fentanyl citrate from the department for his own use, and endangering heart ...
Orexo and Invida jointly announce agreement for Abstral™ in Asia Pacific: Abstral is a fast-acting and rapidly disintegrating sublingual tablet formulation of fentanyl citrate designed for oral transmucosal delivery. The product offers patients and clinicians a simple, patient friendly and predictable way of delivering fentanyl ...
Covidien launches generic version of Actiq: In October, Covidien said it expected to start selling six different doses of generic Actiq, or fentanyl citrate, which is a powerful and addictive painkiller. It is approved only for use by cancer patients who are suffering from severe pain that is not ...
ProStrakan Chooses RelayHealth for Approved Abstral REMS Program: Abstral® is a rapidly disintegrating sublingual tablet formulation of fentanyl citrate indicated for the management of breakthrough pain in cancer patients 18 years and older who are already receiving, and are already tolerant to, opioid analgesics for ...
Las Vegas doctor fined for not reporting California sanctions: She was also prohibited from practicing out of her home. California authorities found her guilty of gross negligence in prescribing excessive amounts of the drug Actiq, which two patients became addicted to. Phillips was accused of failing to keep accurate ...

Cephalon off to Record Start in 2010: The company’s guidance is being issued based on certain assumptions including: • Adjusted effective tax rate of approximately 34.0 percent in 2010. • Weighted average number of common shares outstanding of 75.5 and 75.7 million shares for the three ...
FDA Okays Another Fentanyl Product: WASHINGTON -- The FDA has approved another fentanyl transmucosal tablet, Abstral, as a Schedule II opioid to treat breakthrough cancer pain but is requiring prescribers to enroll in a Risk Evaluation and Mitigation Strategy (REMS) program to prevent misuse ...
Snowed In? Your 15 Seconds of Fame Awaits: PHILADELPHIA, Jan. 11, 2011 /PRNewswire/ -- Anyone can get their name and their original love letter on a billboard thanks to Greater Philadelphia Tourism Marketing Corporation's (GPTMC) new contest, beginning today and running through February 4, 2011 ...
Barr posts loss on charges for Pliva acquisition: The company saw strong sales of a newly launched generic version of the Actiq pain treatment. Sales of Barr's generic oral contraceptives rose 19 percent to $114 million. Barr is changing its fiscal year, which had ended in June, to a regular calendar year.
Fentanyl (Buccal Mucosa Route, Oromucosal Route): Fentanyl belongs to the group of medicines called narcotic analgesics, which are medicines used to relieve pain. The oral transmucosal or buccal form of fentanyl is used to treat breakthrough cancer pain. Breakthrough episodes of cancer pain are the flares ...
Spending on narcotics analgesics in comp drops for second year: include OxyContin®, Actiq® and Fentora®. Actiq and OxyContin together make up about $1 of every $8 spent on workers' comp, the study found. Researchers noted that of the top five medication categories in workers ...
Side Effects of Actiq: Actiq is a very serious opiate pain medication that is mostly used in treating types of pain resulting from cancers. This is a drug which doctors use when other medications for pain no longer are helping ...
CHMP Doles Out Two Positive Opinions on Archimedes Pharma and Merck & Co. Drugs: PecFent is an aqueous fentanyl citrate solution that uses Archimedes Pharma’s PecSys™ technology to allow fentanyl to be retained on the nasal mucosa. It is designed to produce rapid but controlled absorption into ...
Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of ...: Archimedes' company-transforming product is PecFent, an innovative and highly differentiated fentanyl citrate nasal spray, now approved for the treatment of breakthrough cancer pain. PecFent is an aqueous fentanyl ...
Watson Pharma Unit Gets Tentative FDA Approval For Fentanyl Citrate Buccal Tablets - Update: (RTTNews) - Watson Pharmaceuticals Inc. (WPI: News ) Wednesday said its subsidiary, Watson Laboratories Inc., received a tentative approval on its Abbreviated New Drug Application, or ANDA, for Fentanyl Citrate Buccal ...

Want to contact a Washington, DC Actiq attorney? ...Get a free case evaluation from one of our Washington, DC Actiq attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: 1 2 Next

Need An Actiq Attorney?

First Name Last Name Email Address State

Legal Issue

FDA Drug Database: Actiq Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Actiq Information

Click to View Our Legal Resources

Want to contact a Washington, DC Actiq attorney? ...Get a free case evaluation from one of our Washington, DC Actiq attorneys now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120521-170445

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

FDA Drug Database: Actiq Click to select a Legal Issue

Close (x)

Find Legal Help for Your Actiq Case - Submit Your Information Below

Do you need legal assistance with your Actiq case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * FDA Drug Database: Actiq Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.